Cargando…

Ab Initio Modelling of the Structure of ToxA-like and MAX Fungal Effector Proteins

Pathogenic fungal diseases in crops are mediated by the release of effector proteins that facilitate infection. Characterising the structure of these fungal effectors is vital to understanding their virulence mechanisms and interactions with their hosts, which is crucial in the breeding of plant cul...

Descripción completa

Detalles Bibliográficos
Autores principales: Rozano, Lina, Mukuka, Yvonne M., Hane, James K., Mancera, Ricardo L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094246/
https://www.ncbi.nlm.nih.gov/pubmed/37047233
http://dx.doi.org/10.3390/ijms24076262
_version_ 1785023793985486848
author Rozano, Lina
Mukuka, Yvonne M.
Hane, James K.
Mancera, Ricardo L.
author_facet Rozano, Lina
Mukuka, Yvonne M.
Hane, James K.
Mancera, Ricardo L.
author_sort Rozano, Lina
collection PubMed
description Pathogenic fungal diseases in crops are mediated by the release of effector proteins that facilitate infection. Characterising the structure of these fungal effectors is vital to understanding their virulence mechanisms and interactions with their hosts, which is crucial in the breeding of plant cultivars for disease resistance. Several effectors have been identified and validated experimentally; however, their lack of sequence conservation often impedes the identification and prediction of their structure using sequence similarity approaches. Structural similarity has, nonetheless, been observed within fungal effector protein families, creating interest in validating the use of computational methods to predict their tertiary structure from their sequence. We used Rosetta ab initio modelling to predict the structures of members of the ToxA-like and MAX effector families for which experimental structures are known to validate this method. An optimised approach was then used to predict the structures of phenotypically validated effectors lacking known structures. Rosetta was found to successfully predict the structure of fungal effectors in the ToxA-like and MAX families, as well as phenotypically validated but structurally unconfirmed effector sequences. Interestingly, potential new effector structural families were identified on the basis of comparisons with structural homologues and the identification of associated protein domains.
format Online
Article
Text
id pubmed-10094246
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100942462023-04-13 Ab Initio Modelling of the Structure of ToxA-like and MAX Fungal Effector Proteins Rozano, Lina Mukuka, Yvonne M. Hane, James K. Mancera, Ricardo L. Int J Mol Sci Article Pathogenic fungal diseases in crops are mediated by the release of effector proteins that facilitate infection. Characterising the structure of these fungal effectors is vital to understanding their virulence mechanisms and interactions with their hosts, which is crucial in the breeding of plant cultivars for disease resistance. Several effectors have been identified and validated experimentally; however, their lack of sequence conservation often impedes the identification and prediction of their structure using sequence similarity approaches. Structural similarity has, nonetheless, been observed within fungal effector protein families, creating interest in validating the use of computational methods to predict their tertiary structure from their sequence. We used Rosetta ab initio modelling to predict the structures of members of the ToxA-like and MAX effector families for which experimental structures are known to validate this method. An optimised approach was then used to predict the structures of phenotypically validated effectors lacking known structures. Rosetta was found to successfully predict the structure of fungal effectors in the ToxA-like and MAX families, as well as phenotypically validated but structurally unconfirmed effector sequences. Interestingly, potential new effector structural families were identified on the basis of comparisons with structural homologues and the identification of associated protein domains. MDPI 2023-03-26 /pmc/articles/PMC10094246/ /pubmed/37047233 http://dx.doi.org/10.3390/ijms24076262 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Rozano, Lina
Mukuka, Yvonne M.
Hane, James K.
Mancera, Ricardo L.
Ab Initio Modelling of the Structure of ToxA-like and MAX Fungal Effector Proteins
title Ab Initio Modelling of the Structure of ToxA-like and MAX Fungal Effector Proteins
title_full Ab Initio Modelling of the Structure of ToxA-like and MAX Fungal Effector Proteins
title_fullStr Ab Initio Modelling of the Structure of ToxA-like and MAX Fungal Effector Proteins
title_full_unstemmed Ab Initio Modelling of the Structure of ToxA-like and MAX Fungal Effector Proteins
title_short Ab Initio Modelling of the Structure of ToxA-like and MAX Fungal Effector Proteins
title_sort ab initio modelling of the structure of toxa-like and max fungal effector proteins
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094246/
https://www.ncbi.nlm.nih.gov/pubmed/37047233
http://dx.doi.org/10.3390/ijms24076262
work_keys_str_mv AT rozanolina abinitiomodellingofthestructureoftoxalikeandmaxfungaleffectorproteins
AT mukukayvonnem abinitiomodellingofthestructureoftoxalikeandmaxfungaleffectorproteins
AT hanejamesk abinitiomodellingofthestructureoftoxalikeandmaxfungaleffectorproteins
AT manceraricardol abinitiomodellingofthestructureoftoxalikeandmaxfungaleffectorproteins